Global Vaccines Market to 2027 - Focus on Influenza, Hepatitis, Respiratory Syncytial Virus, and Other Disease

DUBLIN /PRNewswire/ -- The "Vaccines Market to 2027- Global Analysis and Forecasts by Technology; Disease Indication, Influenza, Hepatitis, Respiratory Syncytial Virus, and Other Diseases); Route of Administration; Patient Type and Geography" report has been added to ResearchAndMarkets.com's offering.

The global vaccines market is expected to reach US$ 64,538.4 Mn in 2027 from US$ 36,998.8 in 2018. The market is estimated to grow with a CAGR of 6.5% from 2019-2027.

The major driving factors are rising prevalence of infectious diseases, growing focus on immunization programs, and increasing support for vaccine development are expected to boost the market growth over the years. However, soaring prices of the vaccines and complexity and cost of vaccine manufacturing are likely to pose a negative impact on the market growth.

On the other hand, robust pipeline of vaccines is likely to have a positive impact on the growth of the global vaccines market in the coming years. In the current era, there are increasing concerns of spread of infectious diseases with the changing environment. These emerging infectious diseases are a burden on public health but have also an impact on global economies. The new diseases such as HIV, hepatitis, dengue have attracted a huge concern for the government of the respective countries. There is also resurgence of diseases which seemed to be under control such as malaria, cholera and many more.

The vaccines market by technology is segmented into Recombinant vaccines, Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, and Toxoid Vaccines. In 2018, the conjugate vaccines segment held a largest market share of 65.1% of the vaccines market, By Technology, This segment is also expected to dominate the market in 2027 as they are the most effective forms of immunization, used to prevent diseases in both infants and adults. Moreover, the similar segment is anticipated to also witness the fastest growth rate of 6.7% during the forecast period, 2019 to 2027 owing to the increasing demand for drugs to treat the disease.

The global vaccines market on the patient type is segmented into pediatric patients and adult patients. In 2018, the pediatric segment held a largest market share of 70.0% of the vaccines market, by patient type. This segment is also expected to dominate the market in 2027 as external immunization is necessary for the new borns. Moreover, vaccines have helped the children in staying healthy and been successful to save millions of lives for more than 50 years.

Key Topics Covered:

1. Introduction

1.1 Scope of the Study

1.2 Report Guidance

1.3 Market Segmentation

2. Global Vaccines Market - Key Takeaways

3. Research Methodology

4. Global Vaccines Market - Market Landscape

4.1 Overview

4.2 Pest Analysis

5. Global Vaccines Market - Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Rising Prevalence of Infectious Diseases

5.1.2 Growing Focus On Immunization Programs

5.1.3 Increasing Support For Vaccine Development

5.2 Key Market Restraints

5.2.1 The Complexity and Cost of Vaccine Manufacturing

5.2.2 Soaring Costs of Vaccines

5.3 Key Market Opportunities

5.3.1 Robust Pipeline of Vaccines

5.4 Future Trends

5.4.1 New Vaccine Delivery Systems

5.5 Impact Analysis

6. Vaccines Market - Global Analysis

6.1 Global Vaccines Market Revenue Forecasts and Analysis

6.2 Global Vaccines Market, by Geography - Forecasts and Analysis

6.3 Performance of Key Players

6.3.1 Glaxosmithkline Plc

6.3.2 Sanofi

7. Vaccines Market Analysis and Forecasts To 2027 - Technology

7.1 Overview

7.2 Technology Market Revenue and Forecasts Analysis (US$ Mn)

7.3 Recombinant Vaccines Market

7.4 Conjugate Vaccines Market

7.5 Live Attenuated Vaccines Market

7.6 Inactivated Vaccines Market

7.7 Toxoid Vaccines Market

8. Vaccines Market Analysis and Forecasts To 2027 - Disease Indication

8.1 Overview

8.2 Disease Indication Market Revenue and Forecasts Analysis (US$ Mn)

8.3 Dtp (Diphtheria, Tetanus, and Pertussis) Market

8.4 Influenza Market

8.5 Hepatitis Market

8.6 Respiratory Syncytial Virus (Rsv) Market

8.7 Other Diseases Market

9. Vaccines Market Analysis and Forecasts To 2027 - Route of Administration

9.1 Overview

9.2 Route of Administration Market Revenue and Forecasts Analysis US$ Mn)

9.3 Oral Market

9.4 Injectable Market

9.5 Other Routes of Administration Market

10. Vaccines Market Analysis and Forecasts To 2027 - Patient Type

10.1 Overview

10.2 Patient Type Market Revenue and Forecasts Analysis (US$ Mn)

10.3 Pediatric Market

10.4 Adults Market

11. Vaccines Market Revenue and Forecasts To 2027 - Geographical Analysis

12. Vaccines Market - Industry Landscape

12.1 Overview

12.2 Comparative Company Analysis

12.3 Growth Strategies Done by the Companies in the Market, (%)

12.4 Organic Developments

12.5 Inorganic Developments

13. Vaccines Market - Key Company Profiles

  • Pfizer
  • GlaxoSmithKline plc.
  • Merck & Co., Inc.
  • Sanofi
  • Johnson & Johnson Services, Inc
  • Panacea Biotec Limited
  • Astellas Pharma Inc.
  • NOVAVAX, INC.
  • VBI Vaccines Inc.
  • Bavarian Nordic

For more information about this report visit https://www.researchandmarkets.com/r/b35ftr

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager 
press@researchandmarkets.com  

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.